{"version":"1.0","type":"link","title":"Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab.","author_name":"Nam H 외","author_url":"https://prs-insight.online/author/Nam%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/105657","thumbnail_width":1200,"thumbnail_height":630}